1. Home
  2. OCFC vs VIR Comparison

OCFC vs VIR Comparison

Compare OCFC & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCFC
  • VIR
  • Stock Information
  • Founded
  • OCFC 1902
  • VIR 2016
  • Country
  • OCFC United States
  • VIR United States
  • Employees
  • OCFC N/A
  • VIR N/A
  • Industry
  • OCFC Major Banks
  • VIR Biotechnology: Pharmaceutical Preparations
  • Sector
  • OCFC Finance
  • VIR Health Care
  • Exchange
  • OCFC Nasdaq
  • VIR Nasdaq
  • Market Cap
  • OCFC 1.0B
  • VIR 859.9M
  • IPO Year
  • OCFC 1996
  • VIR 2019
  • Fundamental
  • Price
  • OCFC $17.98
  • VIR $5.65
  • Analyst Decision
  • OCFC Buy
  • VIR Strong Buy
  • Analyst Count
  • OCFC 5
  • VIR 11
  • Target Price
  • OCFC $21.60
  • VIR $25.73
  • AVG Volume (30 Days)
  • OCFC 491.1K
  • VIR 1.5M
  • Earning Date
  • OCFC 10-22-2025
  • VIR 11-05-2025
  • Dividend Yield
  • OCFC 4.45%
  • VIR N/A
  • EPS Growth
  • OCFC N/A
  • VIR N/A
  • EPS
  • OCFC 1.30
  • VIR N/A
  • Revenue
  • OCFC $378,558,000.00
  • VIR $16,860,000.00
  • Revenue This Year
  • OCFC N/A
  • VIR N/A
  • Revenue Next Year
  • OCFC $12.81
  • VIR $15.25
  • P/E Ratio
  • OCFC $13.84
  • VIR N/A
  • Revenue Growth
  • OCFC N/A
  • VIR N/A
  • 52 Week Low
  • OCFC $14.29
  • VIR $4.16
  • 52 Week High
  • OCFC $21.87
  • VIR $14.45
  • Technical
  • Relative Strength Index (RSI)
  • OCFC 46.85
  • VIR 50.14
  • Support Level
  • OCFC $17.77
  • VIR $4.82
  • Resistance Level
  • OCFC $18.66
  • VIR $5.84
  • Average True Range (ATR)
  • OCFC 0.46
  • VIR 0.37
  • MACD
  • OCFC -0.05
  • VIR -0.03
  • Stochastic Oscillator
  • OCFC 12.87
  • VIR 47.70

About OCFC OceanFirst Financial Corp.

OceanFirst Financial Corp is engaged in the banking sector of the United States. It conducts the business of attracting retail and business deposits and investing them in loans, consisting of single-family, owner-occupied residential mortgage loans, and commercial real estate loans. The company's sole segment deals with the delivery of loan and deposit products to customers. The bank's revenues are derived principally from interest on its loans, and to a lesser extent, interest on its investment and mortgage-backed securities. The rest of its income is dependent on bank card services and wealth management products and services.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: